Table 3.
The Neuroprotective Effect of Compound C in Wild-Type Mice After MCAO (24- or 72-hour survival)
Cortical (%) | Striatal (%) | Total (%) | Scores | |
---|---|---|---|---|
24-hour survival | ||||
Control (n=7) | 36.8±3.2 | 48.0±4.9 | 41.3±4.5 | 2.6±0.21 |
Compound C (n=7) | 18.1±4.1* | 30.0±5.6* | 22.4±3.9* | 1.9±0.24* |
72-hour survival | ||||
Control (n=6) | 54.1±3.6 | 73.6±7.8 | 61.7±3.6 | 3.0±0.4 |
Compound C (n=8) | 31.8±2.1* | 49.4±3.0 | 38.3±2.3* | 1.7±0.1* |
Mice were treated intraperitoneally with 20 mg/kg per body weight of Compound C or vehicle at the onset of the stroke. Cortical, striatal, and total infarct volumes were measured (shown as percentage of the nonischemic hemisphere). Mean±SEM.
P<0.05, one-way analysis of variance, compared with corresponding vehicle-treated mice control. The neurological deficit scores were analyzed by Mann–Whitney U test.